PHENTOLAMINE MESYLATE | NOVARTIS | ||
5MG/VIAL | |||
No | No | ||
Expired | Expired | ||
None | None | ||
None | No | ||
REGITINE for Injection, USP is indicated for the prevention or control of hypertensive episodes that may occur in a patient with pheochromocytoma as a result of stress or manipulation during preoperative preparation and surgical excision. REGITINE for Injection, USP is indicated for the prevention or treatment of dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine. REGITINE for Injection, USP is also indicated for the diagnosis of pheochromocytoma by the Phentolamine Mesylate for Injection, USP blocking test. |
2 | 0 | 2 |
Total Other Developers | None |
---|
Drugs with Suitability | No |
---|
5MG/VIAL | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
No | 2 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|---|---|---|---|---|
****** | ***** | ***** ************ (********), *.* | *********** | ******* *** ** **, */**/**, ******** ******, ****-***, ******** (***) | *** |
****** | ********* **** *** | ********* *.*.* | *********** | *** ***** ******* **, ********, ****** *****, ***** (***) | *** |
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com